![]() ![]() He has mentored both trainees and junior faculty as PI of MSKCC’s K12. As co-chair of the Experimental Therapeutics and Rare Tumor Committee on the Alliance, he has developed new therapeutics trials for patients with rare cancers, ranging from rare forms of thyroid cancer to sarcoma. This has resulted in a series of innovative translational clinical trials with inhibitors of MDM2, MEK, AKT, IGF-1R, mTOR, Notch, PARP, BRD4 and receptor tyrosine kinase inhibitors. More recently, Schwartz has developed novel therapies for rare cancers, especially sarcoma and uveal melanoma. As director of the Laboratory for New Drug Development of Rare Cancers, he developed NCI, FDA, and DOD grant- supported novel targeted agents for bench-top to bedside clinical translational research focusing on drugs that targeted the cell cycle ranging from CDK4 to Chk1. This resulted in the recruitment of key leaders in the areas of early drug development and immunotherapy. His efforts at Columbia similarly focused on precision medicine. As the former Chief of the Melanoma and Sarcoma Service at Memorial Sloan-Kettering Cancer Center (MSKCC), he successfully brought together clinical researchers and basic scientists to establish a highly successful clinical research program that focused on translational clinical trials with small molecule inhibitors and targeted immunologic agents. His post at Case CCC follows 30 years of extensive work in early drug development with bench-top to bedside research in gastrointestinal cancers, melanoma, and sarcoma. Formerly Chief of Hematology and Oncology at Columbia University Irving Medical Center (CUIMC) and Deputy Director of the Herbert Irving Comprehensive Cancer Center, his vision is to establish highly innovative, transformative clinical translational research programs in the field of cancer therapy. Gary Schwartz, MD, is the Director of the Case Comprehensive Cancer Center (Case CCC). Opportunities for Pilot Projects to Support Multi-Investigator Grants.Adolescent and Young Adult Cancer Research Awards.Hematopoietic Biorepository and Cellular Therapy.Athymic Animal & Preclinical Therapeutics.Clinical Oncology Research Career Development Program.Cancer-focused Summer Undergraduate Research (CanSUR).HIV-associated Lung Malignancy Research Center.GI Specialized Program of Research Excellence (SPORE).Cleveland African American Prostate Cancer Project (CAAPP).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |